Company intelligence / Profile preview

Daniel Baum Company

Lancaster, Pennsylvania, United States
Ownership
Private
Development stage
Other
01

Overview

Daniel Baum Company is a private, family-owned U.S. animal health and nutrition company focused on science-based, largely natural products for livestock, poultry, equine, canine, and deer markets. Founded in 1984 and headquartered in Lancaster, Pennsylvania, the company developed out of the Baum family’s food manufacturing business and positions itself as a biotechnology-based provider of animal wellness, productivity, and performance solutions. Its portfolio is commercial rather than drug-development oriented, spanning DBC Ag Products and acquired brands including LIRA GOLD, KAUFFMAN’S Premium Equine Supplements, and Fortitude Canine. The company markets feed supplements, eubiotic and digestive-support products, immune-support products, electrolyte and wellness formulations, and forage-related products through agricultural and veterinary distribution channels. Daniel Baum Company appears to be an operating commercial animal-health business rather than a human biopharma developer with a clinical pipeline.

Therapeutic areas
ImmunologyOtherGastroenterology
Modalities
BiologicMicrobial therapyProteinNon-pharmacological therapy
Industry
Veterinary
02

Partnerships

Kauffman’s Animal Health, Inc. (long-standing manufacturing relationship and 2017 brand/product acquisition arrangement)

Beyond the preview

Go deeper on Daniel Baum Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daniel Baum Company.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call